Antibodies to cyclic citrullinated peptides in psoriatic arthritis: Do classification criteria affect study results? [5]

Journal of Rheumatology

Volumn 33, Issue 2, 2006, Pages 435-436

  Marchesoni, Antonio ^a   Lurati, Alfredomaria ^a   Desiati, Francesca ^a   Rossi, Valeria ^a   Battafarano, Norma ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; RHEUMATOID FACTOR;

ADULT; ARTHRITIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH STATUS; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; QUESTIONNAIRE;

ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; RHEUMATOLOGY;

EID: 32144455199     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Bogliolo L, Alpini C, Caporali R, Scirè CA, Moratti R, Montecucco C. Antibodies to cyclic citrullinated peptides in psoriatic arthritis. J Rheumatol 2005;32:511-5.
2. Moll JMH, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973;3:55-78.
3. Taylor WJ, Marchesoni A, Arreghini M, Sokoll K, Helliwell PS. A comparison of the performance characteristics of classification criteria for the diagnosis of psoriatic arthritis. Semin Arthritis Rhem 2004;34:575-84.
4. Taylor WJ, Helliwell PS, Gladman DD, Mease P, Mielants H, Marchesoni A. A validation of current classification criteria for the diagnosis of psoriatic arthritis - Preliminary results of the CASPAR study [abstract]. Ann Rheum Dis 2005;64 Suppl III:OP0157.
5. Meyer O, Labarre C, Dougados M, et al. Anti-citrullinated protein/peptide antibody assay in early rheumatoid arthritis for predicting five-year radiographic damage. Ann Rheum Dis 2003;62:120-6.